etoposide has been researched along with Acid beta-Glucosidase Deficiency in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (60.00) | 2.80 |
Authors | Studies |
---|---|
Lucari, B; Porea, T; Sutton, VR; Tallis, E | 1 |
Baltogianni, M; Bouza, H; Farmaki, E; Giapros, V; Kosmeri, C; Lianou, L; Lykopoulou, L; Makis, A; Papadakis, V; Papadopoulou, E; Rallis, D; Tzanoudaki, M | 1 |
Anderson, HE; Taylor, MRG | 1 |
Aran, JM; Gottesman, MM; Licht, T; Pastan, I | 1 |
Böhm, P; Einsele, H; Horny, HP; Kunz, W | 1 |
1 review(s) available for etoposide and Acid beta-Glucosidase Deficiency
Article | Year |
---|---|
Adult Gaucher disease in association with primary malignant bone tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gaucher Disease; Humans; Ifosfamide; Male; Prednisone; Radiography; Vincristine | 2001 |
4 other study(ies) available for etoposide and Acid beta-Glucosidase Deficiency
Article | Year |
---|---|
Dual enzyme therapy improves adherence to chemotherapy in a patient with gaucher disease and Ewing sarcoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Doxorubicin; Enzyme Therapy; Etoposide; Female; Gaucher Disease; Humans; Ifosfamide; Sarcoma, Ewing; Vincristine | 2023 |
Gaucher Disease Type 2 Manifested as Hemophagocytic Lymphohistiocytosis in a Neonate in the COVID-19 Era.
Topics: COVID-19; Etoposide; Gaucher Disease; Humans; Infant, Newborn; Lymphohistiocytosis, Hemophagocytic | 2023 |
Consequences of treatment for hemophagocytic lymphohistiocytosis in a patient with undiagnosed Gaucher disease Type 1.
Topics: Adult; Alemtuzumab; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Gaucher Disease; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Osteonecrosis; Prognosis; Young Adult | 2020 |
Complete restoration of glucocerebrosidase deficiency in Gaucher fibroblasts using a bicistronic MDR retrovirus and a new selection strategy.
Topics: Animals; Anthracenes; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Northern; Blotting, Western; Cells, Cultured; Colchicine; Cyclosporins; DNA, Complementary; Doxorubicin; Drug Resistance, Multiple; Etoposide; Fibroblasts; Gaucher Disease; Gene Expression Regulation; Genetic Therapy; Genetic Vectors; Glucosylceramidase; Humans; Mice; Mutagenesis, Insertional; Retroviridae; Transfection; Verapamil | 1996 |